Vir Biotechnology Market Sentiment

SPY759.01+0.44%QQQ692.17+0.24%BTC/USD76,923.26−1.66%DIA522.40+1.02%GLD363.03+2.04%TLT82.05+0.25%

Premium Services

Vir Biotechnology Inc

VIRNASDAQ

Trade with Public

$11.39

0.090.8%

Last update: Nov 2, 7:48 AM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Earnings: Q3 2026 earnings tomorrow on Wed Nov 4th after the market close

Conference Call: Conference call scheduled tomorrow at 4:30 PM

Click to view the webcast

Vir Biotechnology Market Sentiment - Benzinga

Vir Biotechnology Market Sentiment

Market sentiment signals for Vir Biotechnology (VIR): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 10.2% short float

Options Flow— 1.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

1.00

Balanced — Neutral

1 calls · 1 puts

Avg Consensus PT

$21

+82.0%

Highest Price Target

$31

+172.2%

Barclays

Lowest Price Target

$12

+5.4%

Raymond James

Short Interest

10.2%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 7, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+93.2%	$20 → $22	Maintained	Buy
Jun 11, 2026	Morgan Stanley	Michelle Gilson—	+137.1%	$23 → $27	Maintained	Overweight
Jun 3, 2026	Leerink Partners	Roanna Ruiz—	+84.4%	$20 → $21	Maintained	Outperform
Mar 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+75.6%	$15 → $20	Maintained	Buy
Feb 25, 2026	Barclays	Etzer Darout—	+163.4%	$26 → $30	Maintained	Overweight
Feb 24, 2026	Morgan Stanley	Michelle Gilson—	+110.7%	$20 → $24	Maintained	Overweight
Feb 24, 2026	Evercore ISI Group	Cory Kasimov—	+58.0%	$12 → $18	Maintained	Outperform
Feb 24, 2026	Needham	Joseph Stringer—	+58.0%	$14 → $18	Maintained	Buy
Feb 9, 2026	Needham	Joseph Stringer—	+22.9%	$14 → $14	Maintained	Buy
Dec 30, 2025	HC Wainwright & Co.	Patrick R. Trucchio—	+31.7%	$15 → $15	Maintained	Buy
Sep 15, 2025	HC Wainwright & Co.	Patrick R. Trucchio—	+31.7%	$15 → $15	Maintained	Buy
Sep 3, 2025	Evercore ISI Group	Cory Kasimov—	+5.4%	$12	Initiate	Outperform
Aug 27, 2025	B of A Securities	Geoff Meacham—	+22.9%	$12 → $14	Upgrade	Neutral→Buy
Jul 11, 2025	Raymond James	Sean McCutcheon—	+5.4%	$12	Initiate	Outperform
May 22, 2025	Needham	Joseph Stringer—	+22.9%	$14 → $14	Maintained	Buy
May 12, 2025	Needham	Joseph Stringer—	+22.9%	$19 → $14	Maintained	Buy
Apr 17, 2025	Goldman Sachs	Paul Choi—	+84.4%	$28 → $21	Maintained	Buy
Feb 28, 2025	Barclays	Gena Wang—	+172.2%	$26 → $31	Maintained	Overweight
Feb 28, 2025	HC Wainwright & Co.	Patrick Trucchio—	+865.8%	$110 → $110	Maintained	Buy
Feb 27, 2025	Needham	Joseph Stringer—	+66.8%	$19 → $19	Maintained	Buy
Jan 31, 2025	HC Wainwright & Co.	Patrick Trucchio—	+865.8%	$110 → $110	Maintained	Buy
Jan 13, 2025	Leerink Partners	Roanna Ruiz—	+75.6%	$18 → $20	Maintained	Outperform
Jan 10, 2025	HC Wainwright & Co.	Patrick Trucchio—	+865.8%	$110 → $110	Maintained	Buy
Jan 9, 2025	Morgan Stanley	Michelle Gilson—	+75.6%	$10 → $20	Upgrade	Equal-Weight→Overweight
Jan 9, 2025	JP Morgan	Eric Joseph—	+22.9%	$10 → $14	Maintained	Neutral